Načítá se...
Neurophysiological Biomarkers of Parkinson’s Disease
BACKGROUND: There is a need for reliable and robust Parkinson’s disease biomarkers that reflect severity and are sensitive to disease modifying investigational therapeutics. OBJECTIVE: To demonstrate the utility of EEG as a reliable, quantitative biomarker with potential as a pharmacodynamic endpoin...
Uloženo v:
| Vydáno v: | J Parkinsons Dis |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
IOS Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7242849/ https://ncbi.nlm.nih.gov/pubmed/32116262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-191844 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|